NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Bowel cancer
Date of first enrollment	07/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : UFT(tegafur + uracil) INN of investigational material : UFT:tegafur, uracil Therapeutic category code : 422 Antimetabolic agents Dosage and Administration for Investigational material : oral uracil-tegafur 400 mg square meter for one year

Outcome(s)

Primary Outcome	Efficacy and safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	Patients with Dukes C bower cancer who received a surgery of curative resection (curability A).
Exclude criteria